Advances in Cancer Research and Treatment
About Advances in Cancer Research and Treatment
Cancer research is moving faster than ever, with new discoveries in biology, technology and treatment. Advances such as immunotherapy, cell therapy and targeted radiation are changing outlooks for many patients.
The Advances in Cancer Research and Treatment session at Cancer Research 2027 highlights the latest breakthroughs. It connects closely with cancer pathophysiology, where many new treatment ideas begin.
The pace of progress in cancer research has never been faster. New types of treatment are moving from the lab to the clinic in a few years rather than decades. Many of these advances build on a better understanding of the immune system and tumour genetics. This session showcases the most promising new work.
Key Topics in Advances in Cancer Research and Treatment
• New immunotherapy approaches
• CAR-T and engineered cell therapies
• Antibody–drug conjugates and bispecific antibodies
• Personalised cancer vaccines
• Radioligand and theranostic therapies
• RNA-based and gene therapies
• Targeting the tumour microenvironment
• Overcoming treatment resistance
• New technologies in cancer research
• Translating discoveries into care
Recent Advances in Advances in Cancer Research and Treatment
Antibody–drug conjugates and bispecific antibodies are delivering strong results across several cancers. Personalised mRNA cancer vaccines, linked with cancer prevention vaccines, are being tested to prevent cancer returning after surgery.
Theranostics, using imaging from cancer imaging techniques, delivers targeted radiation to tumours. AI from role of artificial intelligence in oncology is speeding up discovery and trial design.
Antibody–drug conjugates are delivering powerful drugs directly to cancer cells. Personalised vaccines are being tested to train the immune system against each patient's tumour. Cell therapies are being adapted for solid tumours, not just blood cancers. Researchers are also exploring ways to overcome resistance to current treatments.
Who Should Attend the Advances in Cancer Research and Treatment Session
• Cancer researchers and translational scientists
• Oncologists and haematologists
• Biotech and pharma R&D teams
• Clinical trial investigators
• PhD students and postdoctoral researchers
• Research funders and investors
Why Present Your Research in Advances in Cancer Research and Treatment
Presenting at Cancer Research 2027 lets you share breakthroughs with an international audience. You can connect with colleagues in clinical research and clinical trials of cancer who test new treatments in patients. Presenting new advances here puts your work in front of clinicians, scientists and industry. It can help speed the path from discovery to patient benefit.
Frequently Asked Questions
Can I present early-phase trial results?
Yes. Early-phase and first-in-human results are welcome.
Does this session include laboratory breakthroughs?
Yes. Preclinical discoveries with clear clinical potential fit this session.
Where is Cancer Research 2027?
Cancer Research 2027 is held at Village Hotel Changi, Singapore, from 8 to 10 March 2027, with online participation.